These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18556207)

  • 1. Antiprion activity of functionalized 9-aminoacridines related to quinacrine.
    Nguyen TH; Lee CY; Teruya K; Ong WY; Doh-ura K; Go ML
    Bioorg Med Chem; 2008 Jul; 16(14):6737-46. PubMed ID: 18556207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments.
    Klingenstein R; Löber S; Kujala P; Godsave S; Leliveld SR; Gmeiner P; Peters PJ; Korth C
    J Neurochem; 2006 Aug; 98(3):748-59. PubMed ID: 16749906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion inhibition with multivalent PrPSc binding compounds.
    Mays CE; Joy S; Li L; Yu L; Genovesi S; West FG; Westaway D
    Biomaterials; 2012 Oct; 33(28):6808-22. PubMed ID: 22748770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.
    May BC; Fafarman AT; Hong SB; Rogers M; Deady LW; Prusiner SB; Cohen FE
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3416-21. PubMed ID: 12626750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-prion activities and drug-like potential of functionalized quinacrine analogs with basic phenyl residues at the 9-amino position.
    Nguyen T; Sakasegawa Y; Doh-Ura K; Go ML
    Eur J Med Chem; 2011 Jul; 46(7):2917-29. PubMed ID: 21531054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar structure-activity relationships of quinoline derivatives for antiprion and antimalarial effects.
    Klingenstein R; Melnyk P; Leliveld SR; Ryckebusch A; Korth C
    J Med Chem; 2006 Aug; 49(17):5300-8. PubMed ID: 16913719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.
    Korth C; May BC; Cohen FE; Prusiner SB
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9836-41. PubMed ID: 11504948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chimeric ligand approach leading to potent antiprion active acridine derivatives: design, synthesis, and biological investigations.
    Dollinger S; Löber S; Klingenstein R; Korth C; Gmeiner P
    J Med Chem; 2006 Nov; 49(22):6591-5. PubMed ID: 17064077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible pharmacological explanation for quinacrine failure to treat prion diseases: pharmacokinetic investigations in a ovine model of scrapie.
    Gayrard V; Picard-Hagen N; Viguié C; Laroute V; Andréoletti O; Toutain PL
    Br J Pharmacol; 2005 Feb; 144(3):386-93. PubMed ID: 15655516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of benzamide derivatives and their evaluation as antiprion agents.
    Fiorino F; Eiden M; Giese A; Severino B; Esposito A; Groschup MH; Perissutti E; Magli E; Incisivo GM; Ciano A; Frecentese F; Kretzschmar HA; Wagner J; Santagada V; Caliendo G
    Bioorg Med Chem; 2012 Aug; 20(16):5001-11. PubMed ID: 22795751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship refinement and further assessment of indole-3-glyoxylamides as a lead series against prion disease.
    Thompson MJ; Louth JC; Ferrara S; Sorrell FJ; Irving BJ; Cochrane EJ; Meijer AJ; Chen B
    ChemMedChem; 2011 Jan; 6(1):115-30. PubMed ID: 21154498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of prion propagation by enantiomers of quinacrine.
    Ryou C; Legname G; Peretz D; Craig JC; Baldwin MA; Prusiner SB
    Lab Invest; 2003 Jun; 83(6):837-43. PubMed ID: 12808118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acridin-9-yl exchange: a proposal for the action of some 9-aminoacridine drugs.
    Sebestík J; Safarík M; Stibor I; Hlavácek J
    Biopolymers; 2006; 84(6):605-14. PubMed ID: 16933221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of 9-aminoacridine drug quinacrine with glutathione limits its antiprion activity.
    Šafařík M; Moško T; Zawada Z; Šafaříková E; Dračínský M; Holada K; Šebestík J
    Chem Biol Drug Des; 2017 Jun; 89(6):932-942. PubMed ID: 27933730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a class of diketopiperazines as antiprion compounds.
    Bolognesi ML; Ai Tran HN; Staderini M; Monaco A; López-Cobeñas A; Bongarzone S; Biarnés X; López-Alvarado P; Cabezas N; Caramelli M; Carloni P; Menéndez JC; Legname G
    ChemMedChem; 2010 Aug; 5(8):1324-34. PubMed ID: 20540064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational approach to an antiprion compound with a multiple mechanism of action.
    Bolognesi ML; Bongarzone S; Aulic S; Ai Tran HN; Prati F; Carloni P; Legname G
    Future Med Chem; 2015; 7(16):2113-20. PubMed ID: 26511069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of monomeric and dimeric acridine compounds as potential therapeutics in Alzheimer and prion diseases.
    Csuk R; Barthel A; Raschke C; Kluge R; Ströhl D; Trieschmann L; Böhm G
    Arch Pharm (Weinheim); 2009 Dec; 342(12):699-709. PubMed ID: 19899100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity.
    Villa V; Tonelli M; Thellung S; Corsaro A; Tasso B; Novelli F; Canu C; Pino A; Chiovitti K; Paludi D; Russo C; Sparatore A; Aceto A; Boido V; Sparatore F; Florio T
    Neurotox Res; 2011 May; 19(4):556-74. PubMed ID: 20405353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and structure-activity relationship of indole-3-glyoxylamide libraries possessing highly potent activity in a cell line model of prion disease.
    Thompson MJ; Borsenberger V; Louth JC; Judd KE; Chen B
    J Med Chem; 2009 Dec; 52(23):7503-11. PubMed ID: 19842664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinacrine reactivity with prion proteins and prion-derived peptides.
    Zawada Z; Šafařík M; Dvořáková E; Janoušková O; Březinová A; Stibor I; Holada K; Bouř P; Hlaváček J; Sebestík J
    Amino Acids; 2013 May; 44(5):1279-92. PubMed ID: 23340659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.